Discrimination by health care workers versus discrimination by others: Countervailing forces on HCV treatment intentions

Psychology, Health and Medicine

Volumn 20, Issue 2, 2015, Pages 148-153

  Brener, Loren ^a   Horwitz, Robyn ^a   Von Hippel, Courtney ^b   Bryant, Joanne ^a   Treloar, Carla ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Hepatitis C; Injecting drug use; Perceived discrimination; Social identity theory; Treatment

Indexed keywords

ADULT; AGED; COMPLICATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGY; SOCIAL DISCRIMINATION; SOCIAL STIGMA; SUBSTANCE ABUSE; YOUNG ADULT;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIAL DISCRIMINATION; SOCIAL STIGMA; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84920929374     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548506.2014.923103     Document Type: Article

References (25)

1. Ahern, J., Stuber, J., & Galea, S. (2007). Stigma, discrimination and the health of illicit drug users. Drug and Alcohol Dependence, 88, 188-196. doi:10.1016/j.drugalcdep.2006.10.014
2. Australian Government Department of Health and Ageing. (2010). Third national hepatitis C strategy 2010-2013. Canberra: Commonwealth of Australia.
3. Brewer, M.B. (1979). In-group bias in the minimal intergroup situation: A cognitive-motivational analysis. Psychological Bulletin, 86, 307-324.
4. Bruggmann, P., Falcato, L., Dober, S., Helbling, B., Keiser, O., Negro, F., & Meili, D. (2008). Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. Journal of Viral Hepatitis, 15, 747-752. doi:10.1111/j.1365-2893.2008.01010.x
5. Butt, G. (2008). Stigma in the context of hepatitis C: Concept analysis. Journal of Advanced Nursing, 62, 712-724.
6. Casey, L.C., & Lee, W.M. (2013). Hepatitis C virus therapy update. Current Opinion Gastroenterology, 29, 243-249.
7. Crofts, N., Louie, R., & Lof, B. (1997). The next plague: Stigmatization and discrimination related to hepatitis C infection in Australia. Health and Human Rights, 2, 86-97.
8. Day, C., Ross, J., & Dolan, K. (2003). Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug and Alcohol Review, 22, 317-321.
9. Dore, G. (2012). The changing therapeutic landscape for hepatitis C. The Medical Journal of Australia, 196, 629-632.
10. von Hippel, C., & Brener, L. (2012). Specificity of discrimination: Does it matter from whence it comes? Journal of Applied Social Psychology, 42, 1029-1042.
11. Hopwood, M., & Treloar, C. (2003). The 3D project: Diagnosis, disclosure, discrimination and living with hepatitis C. Sydney: National Centre in HIV Social Research, University of New South Wales.
12. Hopwood, M., Treloar, C., & Bryant, J. (2006). Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs: Education, Prevention and Policy, 13, 61-75.
13. Martin, N.K., Vickerman, P., Foster, G.R., Hutchinson, S.J., Goldberg, D.J., & Hickman, M. (2011). Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. Journal of Hepatology, 54, 1137-1144. doi:http://dx.doi.org/10.1016/j.jhep.2010.08.029
14. Mehta, S.H., Genberg, B.L., Astemborski, J., Kavasery, R., Kirk, G.D., Vlahov, D., ... Thomas, D.L. (2008). Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health, 33, 126-133. doi:http://dx.doi.org/10.1007/s10900-007-9083-3
15. Melin, P., Chousterman, M., Fontanges, T., Ouzan, D., Rotily, M., Lang, J., ... Cacoub, P. (2010). Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: Results of a prospective cohort study. European Journal of Gastroenterology & Hepatology, 22, 1050-1057. doi:http://dx.doi.org/10.1097/MEG.0b013e328338d9aa
16. Pachankis, J.E. (2007). The psychological implications of concealing a stigma: A cognitive-affective-behavioral model. Psychological Bulletin, 133, 328-345.doi:10.1037/0033-2909.133.2.328
17. Pascoe, E.A., & Smart Richman, L. (2009). Perceived discrimination and health: A meta-analytic review. Psychological Bulletin, 135, 531-554.
18. Razali, K., Thein, H.H., Bell, J., Cooper-Stanburg, M., Dolan, K., Dore, G., ... Law, M. (2007). Modelling the hepatitis C virus epidemic in Australia. Drug and Alcohol Dependence, 91, 228-235. http://dx.doi.org.wwwproxy0.library.unsw.edu.au/10.1016/j.drugalcdep.2007.05.026
19. Robotin, M.C., Copland, J., Tallis, G., Coleman, D., Giele, C., Carter, L., ... Dore, G.J. (2004). Surveillance for newly acquired hepatitis C in Australia. Journal of Gastroenterology Hepatology, 19, 283-288. doi:10.1111/j.1440-1746.2003.03270.x
20. Sylvestre, D.L. (2005). Treating hepatitis C virus infection in active substance users. Clinical Infectious Diseases, 40, S321-S324. Retrieved from http://search.proquest.com/docview/17834983?accountid=12763
21. Tajfel, H.E. (1978). Differentiation between social groups: Studies in the social psychology of intergroup relations. Oxford: Academic Press.
22. Tajfel, H., & Turner, J.C. (1979). An integrative theory of intergroup conflict. The Social Psychology of Intergroup Relations, 33-47.
23. Tajfel, H., & Turner, J.C. (1986). The social identity theory of intergroup behavior. In S. Worchel & W.G. Austin (Eds.), Psychology of intergroup relations (pp. 7-24). Chicago, IL: Nelson-Hall.
24. Treloar, C., & Hopwood, M. (2004). Infection control in the context of hepatitis C disclosure: Implications for education of healthcare professionals. Education for Health, 17, 183-191.
25. Turner, J.C. (1981). Towards a cognitive redefinition of the social group. Cahiers de Psychologie Cognitive/Current Psychology of Cognition, 1, 93-118.